Press release content from Business Wire. The AP news staff was not involved in its creation.
Thrombosis Canada Encourages Patients on Anticoagulant (Blood Thinning) Therapy to Receive a Vaccine to Protect Against COVID-19
December 23, 2020 GMT
TORONTO (BUSINESS WIRE) Dec 23, 2020
Today, Thrombosis Canada is providing immediate guidance to ensure Canadian healthcare professionals and people on anticoagulant (blood thinning) therapy have consistent and accurate information on receiving a vaccination for COVID-19 (according to provincial vaccination plans). For the estimated 1 million Canadians currently receiving anticoagulation therapy, many of whom are elderly and are likely to be at higher risk for coronavirus-related health problems, Thrombosis Canada is encouraging vaccinations, stating that therapy should not be a barrier to the administration of a coronavirus vaccine.